Skip to main content
Top
Published in: BMC Health Services Research 1/2020

Open Access 01-12-2020 | Schizophrenia | Study protocol

An economic evaluation of a mobile text messaging intervention to improve mental health care in resource-poor communities in China: a cost-effectiveness study

Authors: Rubee Dev, Jinghua Li, Donglan Zhang, Yiyuan Cai, Chun Hao, Fengsu Hou, Ruixin Wang, Meijuan Lin, Dong (Roman) Xu

Published in: BMC Health Services Research | Issue 1/2020

Login to get access

Abstract

Background

Severe mental disorders, a leading cause of disability has become a major public health problem. In order to promote mental health, a series of programs have been promulgated by the Chinese government. However, economic evaluations of such programs are lacking. The purpose of this study is to develop and validate an economic model to assess the cost and health outcomes of the LEAN (Lay health supporters, E-platform, Award, and iNtegration) program, and to perform an economic evaluation of LEAN versus the nationwide community-based mental health program that provides free antipsychotic medications.

Methods

A cost-effectiveness and cost-utility analysis of the LEAN intervention will be performed. A Markov model will be developed, validated and used to assess and compare the costs and outcomes for the LEAN intervention versus nationwide community-based mental health program. The calculated sample size is 258 participants for the analysis. A societal perspective will be applied with the time horizon of 1-year after the termination of the LEAN program. The cost-utility will be measured primarily using Quality Adjusted Life Years and the cost-effectiveness will be measured using number of relapses and number of re-hospitalizations avoided 6-month after the intervention. Univariate and probabilistic sensitivity analysis will be conducted for the analysis of uncertainty.

Discussion

If proven cost-effective, this study will contribute to the nationwide implementation of the program, not only for schizophrenia but for all kind of severe mental disorders. Markov model developed as part of the study will benefit potential researchers in analyzing cost-effectiveness of other programs. The Chinese context of the study may limit the generalizability of the study results to some extent.

Trial registration

This study was registered in a Chinese Clinical Trial Registry (ChiCTR2000034962​) on 25 July 2020.
Literature
1.
go back to reference Zhang F, Zhao J. China is Prepared to Fight Against Emerging Mental Health Disorders? Int J Emerg Mental Health Human Resilience. 2015;17:628–34 ISSN 1522-4821. Zhang F, Zhao J. China is Prepared to Fight Against Emerging Mental Health Disorders? Int J Emerg Mental Health Human Resilience. 2015;17:628–34 ISSN 1522-4821.
2.
go back to reference Ran M-S, Weng X, Liu Y-J, Zhang T-M, Thornicroft G, Davidson L, et al. Severe mental disorders in rural China: a longitudinal survey. Lancet. 2017;390:S37.CrossRef Ran M-S, Weng X, Liu Y-J, Zhang T-M, Thornicroft G, Davidson L, et al. Severe mental disorders in rural China: a longitudinal survey. Lancet. 2017;390:S37.CrossRef
3.
go back to reference Charlson FJ, Baxter AJ, Cheng HG, Shidhaye R, Whiteford HA. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. Lancet. 2016;388(10042):376–89.CrossRefPubMed Charlson FJ, Baxter AJ, Cheng HG, Shidhaye R, Whiteford HA. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. Lancet. 2016;388(10042):376–89.CrossRefPubMed
4.
go back to reference Hu X, Rohrbaugh R, Deng Q, He Q, Munger KF, Liu Z. Expanding the mental health workforce in China: narrowing the mental health service gap. Psychiatr Serv. 2017;68(10):987–9.CrossRefPubMed Hu X, Rohrbaugh R, Deng Q, He Q, Munger KF, Liu Z. Expanding the mental health workforce in China: narrowing the mental health service gap. Psychiatr Serv. 2017;68(10):987–9.CrossRefPubMed
5.
go back to reference Wang X, Zhang W, Ma N, Guan L, Law SF, Yu X, et al. Adherence to antipsychotic medication by community-based patients with schizophrenia in China: a cross-sectional study. Psychiatr Serv. 2016;67(4):431–7.CrossRefPubMed Wang X, Zhang W, Ma N, Guan L, Law SF, Yu X, et al. Adherence to antipsychotic medication by community-based patients with schizophrenia in China: a cross-sectional study. Psychiatr Serv. 2016;67(4):431–7.CrossRefPubMed
6.
go back to reference Paganini S, Teigelkötter W, Baumeister H. Economic evaluations of internet-and mobile-based interventions for depression: a systematic review. Euro Health Psychol. 2016;18(S):368. Paganini S, Teigelkötter W, Baumeister H. Economic evaluations of internet-and mobile-based interventions for depression: a systematic review. Euro Health Psychol. 2016;18(S):368.
7.
go back to reference Xu DR, Xiao S, He H, Caine ED, Gloyd S, Simoni J, et al. Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): a randomized controlled trial. PLoS Med. 2019;16(4):e1002785.CrossRefPubMed Xu DR, Xiao S, He H, Caine ED, Gloyd S, Simoni J, et al. Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): a randomized controlled trial. PLoS Med. 2019;16(4):e1002785.CrossRefPubMed
8.
go back to reference Xu DR, Gong W, Caine ED, Xiao S, Hughes JP, Ng M, et al. Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial. BMJ Open. 2016;6(1):e010120.CrossRefPubMed Xu DR, Gong W, Caine ED, Xiao S, Hughes JP, Ng M, et al. Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial. BMJ Open. 2016;6(1):e010120.CrossRefPubMed
9.
go back to reference Becker MH. The health belief model and personal health behavior. Health Educa Monogr. 1974;2:324–473.CrossRef Becker MH. The health belief model and personal health behavior. Health Educa Monogr. 1974;2:324–473.CrossRef
10.
go back to reference Xiao J, Mi W, Li L, Shi Y, Zhang H. High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s republic of China. Neuropsychiatr Dis Treat. 2015;11:1161.PubMedPubMedCentral Xiao J, Mi W, Li L, Shi Y, Zhang H. High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s republic of China. Neuropsychiatr Dis Treat. 2015;11:1161.PubMedPubMedCentral
11.
go back to reference Zhou Y, Ning Y, Rosenheck R, Sun B, Zhang J, Ou Y, et al. Effect of living with patients on caregiver burden of individual with schizophrenia in China. Psychiatry Res. 2016;245:230–7.CrossRefPubMed Zhou Y, Ning Y, Rosenheck R, Sun B, Zhang J, Ou Y, et al. Effect of living with patients on caregiver burden of individual with schizophrenia in China. Psychiatry Res. 2016;245:230–7.CrossRefPubMed
12.
go back to reference Good BJ, Good M-JD. Significance of the 686 program for China and for global mental health. Shanghai Arch Psychiatry. 2012;24(3):175.PubMedPubMedCentral Good BJ, Good M-JD. Significance of the 686 program for China and for global mental health. Shanghai Arch Psychiatry. 2012;24(3):175.PubMedPubMedCentral
13.
go back to reference Liang D, Mays VM, Hwang W-C. Integrated mental health services in China: challenges and planning for the future. Health Policy Plan. 2017;33(1):107–22.CrossRefPubMedCentral Liang D, Mays VM, Hwang W-C. Integrated mental health services in China: challenges and planning for the future. Health Policy Plan. 2017;33(1):107–22.CrossRefPubMedCentral
14.
go back to reference Smith PG, Morrow RH, Ross DA. Intervention costing and economic analysis. Field Trials of Health Interventions: A Toolbox 3rd edition. Oxford: OUP; 2015. Smith PG, Morrow RH, Ross DA. Intervention costing and economic analysis. Field Trials of Health Interventions: A Toolbox 3rd edition. Oxford: OUP; 2015.
16.
go back to reference Smit HFE, Cuijpers P, Oostenbrink J, Batelaan NM, de Graaf R, Beekman AJ. Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ. 2006;9(4):193–200.PubMed Smit HFE, Cuijpers P, Oostenbrink J, Batelaan NM, de Graaf R, Beekman AJ. Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ. 2006;9(4):193–200.PubMed
17.
go back to reference McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.CrossRefPubMed McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616–22.CrossRefPubMed
18.
go back to reference Üstün TB, Kostanjsek N, Chatterji S, Rehm J. Measuring health and disability: Manual for WHO disability assessment schedule WHODAS 2.0: World Health Organization; 2010. Üstün TB, Kostanjsek N, Chatterji S, Rehm J. Measuring health and disability: Manual for WHO disability assessment schedule WHODAS 2.0: World Health Organization; 2010.
19.
go back to reference Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization disability assessment schedule 2.0. Bull World Health Org. 2010;88:815–23.CrossRefPubMedPubMedCentral Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization disability assessment schedule 2.0. Bull World Health Org. 2010;88:815–23.CrossRefPubMedPubMedCentral
20.
go back to reference Haro JM, Kamath SA, Ochoa SO, Novick D, Rele K, Fargas A, et al. The clinical global impression–schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand. 2003;107:16–23.CrossRef Haro JM, Kamath SA, Ochoa SO, Novick D, Rele K, Fargas A, et al. The clinical global impression–schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand. 2003;107:16–23.CrossRef
21.
go back to reference Hakkaart-van Roijen L, Van Straten A, Donker M, Tiemens B. Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TiC-P). Institute for Medical Technology Assessment. 2002. Hakkaart-van Roijen L, Van Straten A, Donker M, Tiemens B. Manual Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TiC-P). Institute for Medical Technology Assessment. 2002.
22.
go back to reference Byerly MJ, Nakonezny PA, Rush AJ. The brief adherence rating scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizoph Res. 2008;100(1–3):60–9.CrossRef Byerly MJ, Nakonezny PA, Rush AJ. The brief adherence rating scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizoph Res. 2008;100(1–3):60–9.CrossRef
23.
go back to reference Vigod SN, Kurdyak PA, Seitz D, Herrmann N, Fung K, Lin E, et al. READMIT: a clinical risk index to predict 30-day readmission after discharge from acute psychiatric units. J Psychiatr Res. 2015;61:205–13.CrossRefPubMed Vigod SN, Kurdyak PA, Seitz D, Herrmann N, Fung K, Lin E, et al. READMIT: a clinical risk index to predict 30-day readmission after discharge from acute psychiatric units. J Psychiatr Res. 2015;61:205–13.CrossRefPubMed
24.
go back to reference Hasan O, Meltzer DO, Shaykevich SA, Bell CM, Kaboli PJ, Auerbach AD, et al. Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med. 2010;25(3):211–9.CrossRefPubMed Hasan O, Meltzer DO, Shaykevich SA, Bell CM, Kaboli PJ, Auerbach AD, et al. Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med. 2010;25(3):211–9.CrossRefPubMed
25.
go back to reference van Walraven C, Dhalla IA, Bell C, Etchells E, Stiell IG, Zarnke K, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010;182(6):551–7.CrossRefPubMedPubMedCentral van Walraven C, Dhalla IA, Bell C, Etchells E, Stiell IG, Zarnke K, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010;182(6):551–7.CrossRefPubMedPubMedCentral
26.
go back to reference Chan CLF, Lai CKY, Chi I. Initial validation of the Chinese interRAI mental health in people with psychiatric illness. Int J Psychiatry Clin Pract. 2014;18(3):182–9.CrossRefPubMed Chan CLF, Lai CKY, Chi I. Initial validation of the Chinese interRAI mental health in people with psychiatric illness. Int J Psychiatry Clin Pract. 2014;18(3):182–9.CrossRefPubMed
27.
go back to reference Hirdes JP, Marhaba M, Smith TF, Clyburn L, Mitchell L, Lemick RA, et al. Development of the resident assessment instrument–mental health (RAI-MH). Hosp Q. 2000;4(2):44–51.PubMed Hirdes JP, Marhaba M, Smith TF, Clyburn L, Mitchell L, Lemick RA, et al. Development of the resident assessment instrument–mental health (RAI-MH). Hosp Q. 2000;4(2):44–51.PubMed
29.
go back to reference Kim J, Ozzoude M, Nakajima S, Shah P, Caravaggio F, Iwata Y, et al. Insight and medication adherence in schizophrenia: an analysis of the CATIE data. Neuropharmacology. 2019;168:107634.CrossRefPubMed Kim J, Ozzoude M, Nakajima S, Shah P, Caravaggio F, Iwata Y, et al. Insight and medication adherence in schizophrenia: an analysis of the CATIE data. Neuropharmacology. 2019;168:107634.CrossRefPubMed
30.
31.
go back to reference Cheung MKT, Hung ATF, Poon PKK, Fong DYT, Li LSW, Chow ESL, et al. Validation of the World Health Organization assessment schedule II Chinese traditional version (WHODAS II CT) in persons with disabilities and chronic illnesses for Chinese population. Disabil Rehabil. 2015;37(20):1902–7.CrossRefPubMed Cheung MKT, Hung ATF, Poon PKK, Fong DYT, Li LSW, Chow ESL, et al. Validation of the World Health Organization assessment schedule II Chinese traditional version (WHODAS II CT) in persons with disabilities and chronic illnesses for Chinese population. Disabil Rehabil. 2015;37(20):1902–7.CrossRefPubMed
32.
go back to reference Chiu T-Y, Yen C-F, Chou C-H, Lin J-D, Hwang A-W, Liao H-F, et al. Development of traditional Chinese version of World Health Organization disability assessment schedule 2.0 36–item (WHODAS 2.0) in Taiwan: validity and reliability analyses. Res Dev Disabil. 2014;35(11):2812–20.CrossRefPubMed Chiu T-Y, Yen C-F, Chou C-H, Lin J-D, Hwang A-W, Liao H-F, et al. Development of traditional Chinese version of World Health Organization disability assessment schedule 2.0 36–item (WHODAS 2.0) in Taiwan: validity and reliability analyses. Res Dev Disabil. 2014;35(11):2812–20.CrossRefPubMed
34.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed
35.
go back to reference Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Mak. 1993;13(4):322–38.CrossRef Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Mak. 1993;13(4):322–38.CrossRef
36.
go back to reference Park RE, Fink A, Brook RH, Chassin MR, Kahn KL, Merrick NJ, et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health. 1986;76(7):766–72.CrossRefPubMedPubMedCentral Park RE, Fink A, Brook RH, Chassin MR, Kahn KL, Merrick NJ, et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health. 1986;76(7):766–72.CrossRefPubMedPubMedCentral
37.
go back to reference Halpern EF, Weinstein MC, Hunink MGM, Gazelle GS. Representing both first-and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Mak. 2000;20(3):314–22.CrossRef Halpern EF, Weinstein MC, Hunink MGM, Gazelle GS. Representing both first-and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Mak. 2000;20(3):314–22.CrossRef
38.
go back to reference McCabe C, Dixon S. Testing the validity of cost-effectiveness models. Pharmacoeconomics. 2000;17(5):501–13.CrossRefPubMed McCabe C, Dixon S. Testing the validity of cost-effectiveness models. Pharmacoeconomics. 2000;17(5):501–13.CrossRefPubMed
39.
go back to reference Palmer CS, Brunner E, Ruı́z-Flores LG, Paez-Agraz F, Revicki DA. A cost-effectiveness clinical decision analysis model for treatment of schizophrenia. Arc Med Res. 2002;33(6):572–80.CrossRef Palmer CS, Brunner E, Ruı́z-Flores LG, Paez-Agraz F, Revicki DA. A cost-effectiveness clinical decision analysis model for treatment of schizophrenia. Arc Med Res. 2002;33(6):572–80.CrossRef
40.
go back to reference Edwards NC, Rupnow MFT, Pashos CL, Botteman MF, Diamond RJ. Cost-effectiveness model of long-acting risperidone in schizophrenia in the US. Pharmacoeconomics. 2005;23(3):299–314.CrossRefPubMed Edwards NC, Rupnow MFT, Pashos CL, Botteman MF, Diamond RJ. Cost-effectiveness model of long-acting risperidone in schizophrenia in the US. Pharmacoeconomics. 2005;23(3):299–314.CrossRefPubMed
41.
go back to reference Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015.
43.
go back to reference Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Value Health. 2005;8(5):521–33.CrossRefPubMed Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Value Health. 2005;8(5):521–33.CrossRefPubMed
Metadata
Title
An economic evaluation of a mobile text messaging intervention to improve mental health care in resource-poor communities in China: a cost-effectiveness study
Authors
Rubee Dev
Jinghua Li
Donglan Zhang
Yiyuan Cai
Chun Hao
Fengsu Hou
Ruixin Wang
Meijuan Lin
Dong (Roman) Xu
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Schizophrenia
Published in
BMC Health Services Research / Issue 1/2020
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-020-05855-6

Other articles of this Issue 1/2020

BMC Health Services Research 1/2020 Go to the issue